GlassScriptPhysician profile
Monica Gomez
NPI 1730723990
$6,306.43
in general payments reported to CMS, 2019-2025
32 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $978 · 2022: $1,302 · 2023: $1,520 · 2024: $1,128 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,025.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,304.52 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,253.62 | 2021-2025 | Breztri, Airsupra, Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $955.49 | 2021-2024 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $724.11 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Grifols USA, LLC | $206.74 | 2021-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $170.13 | 2021-2024 | Uptravi, Opsumit |
| Paratek Pharmaceuticals, INC. | $158.93 | 2022-2025 | Nuzyra |
| Insmed, INC. | $132.22 | 2022-2025 | Arikayce |
| Mylan Specialty L.P. | $131.88 | 2021 | |
| Abiomed | $128.40 | 2025 | |
| Baxter Healthcare | $120.83 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Fisher & Paykel Healthcare INC | $117.26 | 2022-2024 | Fisher & Paykel Healthcare |
| Verona Pharma, INC. | $112.97 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $96.26 | 2022-2024 | Tyvaso |
| Amgen INC. | $94.70 | 2022-2025 | Tezspire |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $70.10 | 2021-2024 | Dupixent |
| Ani Pharmaceuticals, INC. | $68.16 | 2024-2025 | Purified Cortrophin Gel |
| Electromed, INC. | $63.92 | 2021-2022 | |
| Genzyme Corporation | $60.59 | 2021-2025 | |
| Advanced Respiratory, INC | $58.25 | 2021 | |
| Jazz Pharmaceuticals INC. | $39.77 | 2021 | |
| Resmed Corp | $32.15 | 2022 | |
| Abbvie INC. | $30.74 | 2021 | |
| Olympus America INC. | $29.19 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.26 | 2025 | Rexulti |
| Boston Scientific Corporation | $24.09 | 2021 | |
| Tactile Systems Technology INC | $19.08 | 2025 | Nimbl, Flexitouch Plus |
| Nabriva Therapeutics, Plc | $18.46 | 2022 | |
| Merck Sharp & Dohme LLC | $17.11 | 2024 | Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $15.91 | 2022 | |
| Lilly USA, LLC | $14.71 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.